As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.
11 Analysts have issued a Fractyl Health forecast:
11 Analysts have issued a Fractyl Health forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 0.02 0.02 |
83%
83%
|
|
| Gross Profit | 0.01 0.01 |
80%
80%
|
|
| EBITDA | -99 -99 |
39%
39%
|
|
| EBIT (Operating Income) EBIT | -100 -100 |
40%
40%
|
|
| Net Profit | -100 -100 |
51%
51%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
| Head office | United States |
| CEO | Harith Rajagopalan |
| Employees | 103 |
| Founded | 2010 |
| Website | www.fractyl.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


